Family Medicine · Bastrop, LA
NPI
1083714117
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
540 Durham St
Bastrop, LA, 71220
Phone (318) 283-2200
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
1,607 services
Medicare patients, 2024
87
Average age 68
Drug cost, 2024
$951K
10,125 prescriptions
Company payments, 2025
$1,412
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tahir M Qayyum was code 99213 (office e&m - established), 604 times for 78 patients. In total Tahir M Qayyum billed 1,607 services in 24 codes, and Medicare paid $63K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 604 | 78 | $60.05 | $36K |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 330 | 48 | $0.52 | $171 |
| 96372 Injection Administration | Office | 238 | 55 | $9.38 | $2,232 |
| 99214 Office E&M - Established | Office | 179 | 70 | $87.34 | $16K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 49 | 25 | $0.69 | $34.05 |
| G0008 Administration of influenza virus vaccine | Office | 49 | 48 | $19.64 | $962 |
| 90661 Vaccine Product | Office | 35 | 34 | $23.10 | $809 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 33 | 33 | $119.90 | $3,957 |
| 94060 Pulmonary Function Testing | Office | 18 | 15 | $25.07 | $451 |
By year: 2022 $64K for 1,626 services; 2023 $67K for 1,570 services; 2024 $63K for 1,607 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tahir M Qayyum prescribed most often to Medicare patients was Omeprazole, with 505 prescriptions and refills. In total Tahir M Qayyum wrote 10,125 Medicare prescriptions that cost $951K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 505 | 676 | 108 | $3,413 |
| Amlodipine Besylate Generic | 495 | 664 | 78 | $1,503 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 352 | 463 | 64 | $2,602 |
| Metoprolol Tartrate Generic | 324 | 436 | 53 | $1,024 |
| Diclofenac Sodium Generic | 292 | 320 | 80 | $4,140 |
| Levocetirizine Dihydrochloride Generic | 287 | 309 | 133 | $1,002 |
| Nifedipine Er Nifedipine | 241 | 329 | 40 | $2,686 |
| Hydralazine Hcl Generic | 239 | 309 | 50 | $2,227 |
| Prednisone Generic | 238 | 238 | 123 | $312 |
| Pravastatin Sodium Generic | 238 | 370 | 39 | $1,704 |
| Rosuvastatin Calcium Generic | 235 | 325 | 46 | $2,504 |
| Levothyroxine Sodium Generic | 217 | 295 | 37 | $1,171 |
| Atorvastatin Calcium Generic | 188 | 268 | 38 | $768 |
| Gabapentin Generic | 180 | 215 | 33 | $1,181 |
| Ozempic Semaglutide | 175 | 202 | 36 | $175K |
Brand drugs: 1,524 claims; generic drugs: 8,550 claims; opioid claims: 160.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tahir M Qayyum $1,412 ($1,412 in general payments such as food, travel and fees) from 14 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $292.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 9 | $292 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 13 | $290 |
| Sumitomo Pharma America, Inc. 4506.T | 11 | $261 |
| Axsome Therapeutics, Inc. AXSM | 3 | $148 |
| Novo Nordisk Inc NVO | 4 | $78.56 |
| Ardelyx, Inc. ARDX | 3 | $72.95 |
| Alpha Cognition USA, Inc. ACOG | 1 | $55.48 |
| Abbvie Inc. ABBV | 2 | $53.2 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $51.41 |
| Phathom Pharmaceuticals, Inc. PHAT | 2 | $26.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.